MERIT, a company specializing in clinical trial services, has ventured into venture capital, particularly focusing on early-stage biotech startups. MERIT leverages its deep expertise and insights gained from its role in drug development to identify promising investment opportunities. This "insight investing" approach, combined with MERIT's strong network in specialized therapeutic areas like ophthalmology, enables the company to make informed investment decisions, mitigating risk and promoting a robust healthcare ecosystem.